科前生物(688526)9月29日公告，根据《兽药管理条例》和《兽药注册办法》规定，经中华人民共和国 农业农村部审查，批准公司申报的猪塞内卡病毒病灭活疫苗（HB16株，悬浮培养）为新兽药，并核发 《新兽药注册证书》。 ...

Group 1 - The company Hasi Lian (SZ 002900) held its 23rd meeting of the fourth board of directors on August 25, 2025, via telecommunication voting, discussing the proposal for the 2025 semi-annual report [1] - For the year 2024, Hasi Lian's revenue composition is as follows: pharmaceutical industry 87.34%, veterinary medicine 6.64%, other businesses 5.44%, cosmetics 0.45%, and functional foods 0.12% [1] - As of the report date, Hasi Lian's market capitalization is 4.7 billion yuan [1] Group 2 - The pet industry is experiencing significant growth, with a market size of 300 billion yuan, leading to a surge in stock prices for related companies [1]